Valeant Pharma (VRX) in Advanced talks to Sell Salix to Takeda for $10B - DJ

November 1, 2016 3:36 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

(Updated - November 1, 2016 3:39 PM EDT)

Valeant Pharma (NYSE: VRX) is in advanced talks to sell Salix to Takeda for $10 billion, according to Dow Jones, citing sources. Another unnamed bidder is said to be circling Salix.

A deal could be reached in the coming weeks.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment